Fox Run Management, L.L.C. Sangamo Therapeutics, Inc Transaction History

Fox Run Management, L.L.C.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$4.27 - $6.39 $51,052 - $76,398	11,956 New	11,956 $59,000
Q3 2021 Nov 15, 2021	SELL	$9.01 - $12.01 $110,561 - $147,374	-12,271 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$10.17 - $12.64 $124,796 - $155,105	12,271 New	12,271 $147,000
Q3 2018 Oct 05, 2018	SELL	$13.05 - $19.05 $162,942 - $237,858	-12,486 Closed	0 $0
Q2 2018 Jul 17, 2018	SELL	$13.9 - $19.8 $172,707 - $246,015	-12,425 Reduced 49.88%	12,486 $177,000
Q1 2018 Apr 17, 2018	SELL	$16.7 - $26.35 $637,338 - $1.01 Million	-38,164 Reduced 60.51%	24,911 $473,000
Q4 2017 Jan 18, 2018	BUY	$11.6 - $17.35 $570,430 - $853,186	49,175 Added 353.78%	63,075 $1.03 Million
Q3 2017 Oct 23, 2017	BUY	$8.4 - $15.0 $116,760 - $208,500	13,900	13,900 $209,000

134

52.5M

1.02M

1.61M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $183M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.